Document is current
Any future updates will be listed below
-
Authors
Ghadimi, Sara
Ereso, Jason
Kaula, Alexander J.
Taptiklis, Nick
Cormack, Francesca
Alessi, Cathy
Martin, Jennifer L.
Dzierzewski, Joseph M.
Naeim, Arash
Kremen, Sarah
Te, Tue
Fung, Constance H.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AG057929-03S1, R01AG057929, R01AG057929-03S1, R01AG057929-03S1, R01AG057929, R01AG057929-03S1, R01AG057929-03S1, R01AG057929-03S1)
U.S. Department of Veterans Affairs (RCS20-191)
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 26 March 2025
First Online: 1 July 2025
Declarations
:
: Ethics approval was granted by the University of California, Los Angeles Institutional Review Board, and written informed consent to participate was obtained from each participant.
: Not applicable.
: AK, NT, and FC are employed by Cambridge Cognition, which produces Neurovocalix.
